Can systemic cytokines predict relapse of inflammatory bowel disease?

Abstract

BACKGROUND/AIMS To determine the value of systemic cytokines as predictors of relapse in inflammatory bowel disease (IBD). METHODOLOGY A prospective study with 135 patients in clinical remission for at least 3 months. At enrollment, a venous blood was drawn in order to measure, by an ELISA test, the following cytokines: TNFalpha, TNFalpha-R1 and R2, IL-16… (More)

Topics

  • Presentations referencing similar topics